The Impact of Migrations on the Health Services for Rare Diseases in Europe: The Example of Haemoglobin Disorders
Open Access
- 18 March 2013
- journal article
- research article
- Published by Hindawi Limited in The Scientific World Journal
- Vol. 2013, 1-10
- https://doi.org/10.1155/2013/727905
Abstract
Migration from different parts of the world to several European countries leads to the introduction of haemoglobinopathy genes into the population, which creates several demanding needs for prevention and treatment services for Hb disorders. In this paper we examined the degree to which European health services have responded to such challenges and in particular to health services necessary to address the needs of patients with thalassaemia and sickle cell disease (SCD). Information on available services was obtained from international organizations, collaborated European project, and the Thalassaemia International Federation (TIF) Databases, which include information from published surveys, registries, field trips, and delegation visits to countries and regions by expert advisors, local associations, and other collaborators reports. Results show that countries with traditional strong prevention and treatment programs are well prepared to face the above challenges, while others are urgently needed to address these problems in a systematic way. The Thalassaemia International Federation (TIF) is committed to monitor the progress, raise awareness, and support the promotion of more immigrant-oriented health policies to ensure their integration in society and their access to appropriate, adequate, and timely health services. Migration from different parts of the world to several European countries leads to the introduction of haemoglobinopathy genes into the population, which creates several demanding needs for prevention and treatment services for Hb disorders. In this paper we examined the degree to which European health services have responded to such challenges and in particular to health services necessary to address the needs of patients with thalassaemia and sickle cell disease (SCD). Information on available services was obtained from international organizations, collaborated European project, and the Thalassaemia International Federation (TIF) Databases, which include information from published surveys, registries, field trips, and delegation visits to countries and regions by expert advisors, local associations, and other collaborators reports. Results show that countries with traditional strong prevention and treatment programs are well prepared to face the above challenges, while others are urgently needed to address these problems in a systematic way. The Thalassaemia International Federation (TIF) is committed to monitor the progress, raise awareness, and support the promotion of more immigrant-oriented health policies to ensure their integration in society and their access to appropriate, adequate, and timely health services.Funding Information
- Executive Agency for Health and Consumers (2008 12 10)
This publication has 24 references indexed in Scilit:
- Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimatesThe Lancet, 2012
- Interpretations of informed choice in antenatal screening: A cross-cultural, Q-methodology studySocial Science & Medicine (1982), 2012
- Sickle cell and thalassaemia: global public health issues come of ageEthnicity & Health, 2011
- The Management of Iron Chelation Therapy: Preliminary Data from a National Registry of Thalassaemic PatientsAnemia, 2011
- Complications and treatment of patients with -thalassemia in France: results of the National RegistryHaematologica, 2009
- Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in the Netherlands: a pilot study among the general public and primary care providersBMC Public Health, 2009
- Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonanceJournal of Cardiovascular Magnetic Resonance, 2008
- Estimating the attitude of immigrants toward primary prevention of the hemoglobinopathiesPrenatal Diagnosis, 2005
- The UK control programme for the haemoglobin disordersFetal and Maternal Medicine Review, 1994
- PREVENTION OF THALASSAEMIA MAJOR IN LATIUM (ITALY)The Lancet, 1985